Guangdong Hybribio Biotech Co.,Ltd. (SHE:300639)

China · Delayed Price · Currency is CNY

6.75

-0.10 (-1.46%)

Feb 26, 2026, 3:04 PM CST

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
in Vitro Diagnostic Reagents, Supporting Instruments and Consumables	673.49M	-	-	-	-
Medical Testing Services	310.78M	-	-	-	-
Medical Services	6.06M	-	-	-	-
Intersegment elimination	-174.80M	-	-	-	-
Total	815.53M	-	-	-	-

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
China	792.15M	1.03B	3.93B	1.86B	1.17B
China Growth	-23.19%	-73.76%	110.84%	58.73%	67.18%
Overseas	23.38M	73.12M	1.67B	808.78M	180.05M
Overseas Growth	-68.02%	-95.61%	106.03%	349.20%	569.57%
Total	815.53M	1.10B	5.60B	2.67B	1.35B
Total Growth	-26.16%	-80.27%	109.39%	97.34%	85.70%

Source: S&P Global Market Intelligence.